PowellJTaylorJGarlandSG. Andexanet alfa: a novel factor Xa inhibitor reversal agent [published online February 27, 2019]. Ann Pharmacother. 2019;53(9):940-946. doi:10.1177/1060028019835209
2.
GilbertBWReederJAAlkhalifahMAMoranDACorvinoMA. Throwing it in reverse: an update on reversal of oral factor Xa inhibitors [published online April8, 2019]. Am J Emerg Med. doi:10.1016/j.ajem.2019.04.007
3.
BergerKSantibañezMLinLLeschCA. A low-dose 4F-PCC protocol for DOAC-associated intracranial hemorrhage [published online April 14, 2019]. J Intensive Care Med. doi:10.1177/0885066619840992
4.
ConnollySJMillingTJJrEikelboomJW.Full study report of andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2019;380:1326-1335.
